Colorectal, renal, multiple myeloma, gallbladder, uterine corpus, and pancreatic cancers were all linked to obesity.
According to a large study conducted in the United States, the millennial younger generation is at an increased risk of obesity-related cancer.
The American Cancer Association published a study that looked at two decades of cancer incidence data from 1995 to 2014 for 30 different forms of cancer. It spanned 25 states and encompassed nearly two-thirds of the US population (67 percent). In comparison to previous generations, the younger generation’s risk of obesity-related cancer is worrying, according to the study.
When the data was examined during the duration of the study, the rate of younger persons being impacted by other types of cancer remained predictable or decreased in 16 of the 18 cancer types.
Ahmedin Jemal, Ph.D. said, “ The findings are important to public health implications, Even though the absolute risk of these cancers is small in younger adults”.
The researchers are concerned about the alarming rate at which obesity-related cancer is increasing in the younger generation, as well as the implications for them as they grow older. The National Cancer Institute has identified 13 malignancies that have an elevated risk of being affected by obesity, with the possibility of more being added in the future. The researchers said that they don’t know how fat increases the risk of some malignancies, although there are various ideas.
But they noted that obesity is often associated with :
- Inflammation levels are higher, which is a risk factor for several cancers.
- Fat cells release hormones like estrogen, which can disrupt the normal growth of specific cell types, raising the risk of malignancies of the breast, endometrial, and ovaries.
“Given the large increase in the prevalence of overweight and obesity among young people and increasing risks of obesity-related cancers in contemporary birth cohorts, the future burden of these cancers could worsen as younger cohorts age, potentially halting or reversing the progress achieved in reducing cancer mortality over the past several decades,” said Jemal
Parvathy Sukumaran 
